The target cells of injected type I interferons in mouse liver

被引:4
|
作者
Asada-Kubota, M [1 ]
Tatsumi, R [1 ]
Ueda, T [1 ]
Kobayashi, M [1 ]
Hamada, K [1 ]
Maekawa, S [1 ]
Sokawa, Y [1 ]
机构
[1] Kyoto Inst Technol, Dept Biotechnol, Sakyo Ku, Kyoto 606, Japan
来源
关键词
D O I
10.1089/jir.1998.18.71
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Type I interferons (IFNs) have been used for the treatment of viral hepatitis, but it is unclear which cells in the liver are affected by injected IFN, The effects of IFN have been studied by the production of 2',5'-oligoadenylate synthetase (2'5'OAS), an IFN-inducible enzyme, Here, we studied the distribution of 2'5'OAS in mouse liver after injection of natural mouse IFN-alpha/beta by Western blotting and immunohistochemistry using a monoclonal antibody specific to mouse 42-kDa 2'5'OAS, Injection of IFN-alpha/beta increased the levels of liver 2'5'OAS and enhanced the intensities of immunohistochemical staining for this enzyme in both hepatocytes and Kupffer cells, In IFN-untreated normal mice, hepatocytes were lightly stained, but some of the Kupffer cells showed rather strong staining, The 2'5'OAS-positive Kupffer cells comprised similar to 60% of those in normal liver, whereas this increased to similar to 90% following IFN-alpha/beta injection, Thus, hepatocytes and Kupffer cells were the targets of injected IFN.
引用
收藏
页码:71 / 74
页数:4
相关论文
共 50 条
  • [1] Type I interferons inhibit maturation and activation of mouse Langerhans cells
    Fujita, H
    Asahina, A
    Tada, Y
    Fujiwara, H
    Tamaki, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (01) : 126 - 133
  • [2] Novel bioassays for mouse type I and type III interferons
    Kugel, Daniela
    Pulverer, Julia Elisabeth
    Koester, Mario
    Hauser, Hansjoerg
    Staeheli, Peter
    CYTOKINE, 2009, 48 (1-2) : 88 - 88
  • [3] Type I Interferons Interfere with Liver Glucose Metabolism
    Parlakgul, Gunes
    Hotamisligil, Gokhan S.
    CELL METABOLISM, 2017, 25 (06) : 1211 - 1212
  • [4] The probacterial activity of Type I interferons: a target for disease intervention?
    Sher, Alan
    Antonelli, L.
    Feng, C.
    Costa, D.
    Andrade, B.
    O'Garra, A.
    Mayer-Marber, K.
    CYTOKINE, 2015, 76 (01) : 59 - 60
  • [5] Control of Hepatitis C Virus Replication in Mouse Liver-Derived Cells by MAVS-Dependent Production of Type I and Type III Interferons
    Anggakusuma
    Frentzen, Anne
    Guerlevik, Engin
    Yuan, Qinggong
    Steinmann, Eike
    Ott, Michael
    Staeheli, Peter
    Schmid-Burgk, Jonathan
    Schmidt, Tobias
    Hornung, Veit
    Kuehnel, Florian
    Pietschmann, Thomas
    JOURNAL OF VIROLOGY, 2015, 89 (07) : 3833 - 3845
  • [6] Type I interferons and dendritic cells in cancer immunotherapy
    Sprooten, Jenny
    Agostinis, Patrizia
    Garg, Abhishek D.
    IMMUNOBIOLOGY OF DENDRITIC CELLS, PT A, 2019, 348 : 217 - 262
  • [7] Antibody-fused interferons as an effective approach to enhance target specificity and antiviral efficacy of type I interferons
    Lucy S Cheng
    Seungmin Hwang
    Tzu-Hsuan Huang
    Ting-Chang Sheu
    Ren Sun
    Sherie L Morrison
    Genhong Cheng
    Arash Shahangian
    Cell Research, 2008, 18 : 1230 - 1232
  • [8] Type I interferons keep activated T cells alive
    Marrack, P
    Kappler, J
    Mitchell, T
    JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (03): : 521 - 529
  • [9] Production of type I interferons: plasmacytoid dendritic cells and beyond
    Asselin-Paturel, C
    Trinchieri, G
    JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (04): : 461 - 465
  • [10] Antibody-fused interferons as an effective approach to enhance target specificity and antiviral efficacy of type I interferons
    Cheng, Lucy S.
    Hwang, Seungmin
    Huang, Tzu-Hsuan
    Sheu, Ting-Chang
    Sun, Ren
    Morrison, Sherie L.
    Cheng, Genhong
    Shahangian, Arash
    CELL RESEARCH, 2008, 18 (12) : 1230 - 1232